Готові списки джерел за темами / 907/.2

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій

Добірка наукової літератури з теми "907/.2"

Автор: Grafiati
Опубліковано: 26 липня 2024
Оновлено: 31 липня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "907/.2".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "907/.2"

1

Sun, Kaiming, Ruzanna Atoyan, Mylissa A. Borek, et al. "The Combination of Venetoclax and CUDC-907 Exhibits Synergistic Activity in Venetoclax-Refractory DLBCL." Blood 128, no. 22 (2016): 4184. http://dx.doi.org/10.1182/blood.v128.22.4184.4184.

Повний текст джерела
Анотація:
Abstract CUDC-907 is a first-in-class, oral, dual inhibitor of Class I and II HDAC, as well as Class I PI3K enzymes. Specifically, CUDC-907 is designed to inhibit HDACs 1, 2, 3, 6 and 10 and PI3K-alpha, delta and beta isoform. Preclinical studies demonstrate that CUDC-907 has potent effects on acetylated histone-regulated genes and PI3K signaling. CUDC-907 showed potent antitumor activity in multiple preclinical tumor models as well as in patients with relapsed or refractory diffuse large B-cell lymphoma (RR DLBCL), with objective responses reported in multiple patients, including complete res
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Knight, Tristan, Xinan Qiao, Jun Ma, et al. "The Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML." Blood 134, Supplement_1 (2019): 1262. http://dx.doi.org/10.1182/blood-2019-123793.

Повний текст джерела
Анотація:
Introduction FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutations are found in approximately one quarter of acute myeloid leukemia (AML) cases. Its presence results in constitutive activation of the FLT3 receptor tyrosine kinase and its downstream growth/pro-survival pathways including MAPK/ERK, PI3K/AKT, and JAK/STAT, and confers a poor prognosis. Gilteritinib is a selective inhibitor of FLT3 recently approved by the Food and Drug Administration for treatment of patients with relapsed/refractory AML and a FLT3 mutation. However, gilteritinib exposure induces upregulatio
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Younes, Anas, Jesus G. Berdeja, Manish R. Patel, et al. "Phase 1 Trial Testing Single Agent CUDC-907, a Novel, Oral Dual Inhibitor of Histone Deacetylase (HDAC) and PI3K: Initial Assessment of Patients with Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL), Including Double Expressor (DE) Lymphoma." Blood 126, no. 23 (2015): 257. http://dx.doi.org/10.1182/blood.v126.23.257.257.

Повний текст джерела
Анотація:
Abstract DLBCL, the most common lymphoid malignancy in adults, is an aggressive form of non-Hodgkin lymphoma (NHL) with significant heterogeneity in terms of gene expression, prognosis and response to treatment. Certain histone modifications and HDAC expression patterns have been implicated in the pathobiology of DLBCL and other cancers. Aberrant PTEN/PI3K/AKT signaling is also frequently observed in a variety of human cancers including DLBCL, where loss of PTEN activity and/or activating mutations in PI3K and AKT have been shown to reduce apoptosis and promote cell proliferation. Synergistic
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Shulman, David Stephen, Clay Gustafson, Kieuhoa Tran Vo, et al. "Phase 1 multicenter trial of CUDC-907 in children and young adults with relapsed or refractory solid tumors, CNS tumors, and lymphoma." Journal of Clinical Oncology 35, no. 15_suppl (2017): TPS10576. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps10576.

Повний текст джерела
Анотація:
TPS10576 Background: CUDC-907 is an oral first-in-class small molecule inhibitor of histone deacetylases (HDACs) and phosphatidylinositol-3-kinases (PI3Ks), two enzyme classes commonly implicated in pediatric malignancies. Preclinical data demonstrate that inhibition of these enzymes decreases tumor growth across a range of histologies. Data from preclinical and clinical studies suggest that down-regulation of Myc or Mycn signaling may be important in the antineoplastic effects of CUDC-907. Myc or Mycn signaling appears to drive a number of pediatric cancers, heralds a poor prognosis in many o
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zhang, Dongyun, Robert Damoiseaux, Lilit Babayan, et al. "Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease." Journal of Clinical Endocrinology & Metabolism 106, no. 1 (2020): e232-e246. http://dx.doi.org/10.1210/clinem/dgaa699.

Повний текст джерела
Анотація:
Abstract Context Cushing disease (CD) is a life-threatening disorder. Therapeutic goals include symptom relief, biochemical control, and tumor growth inhibition. Current medical therapies for CD by and large exert no action on tumor growth. Objective To identify drugs that inhibit corticotroph tumor adrenocorticotropic hormone (ACTH) secretion and growth. Design High throughput screen employing a novel “gain of signal” ACTH AlphaLISA assay. Setting Academic medical center. Patients Corticotroph tumor tissues from patients with CD. Interventions None. Main outcome measures Potent inhibitors of
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Soosainathan, Arany, Joanna Nikitorowicz-Buniak, Sunil Pancholi, et al. "Abstract P4-02-05: Exploiting novel models of endocrine-resistant breast cancer to identify new therapeutic targets." Cancer Research 82, no. 4_Supplement (2022): P4–02–05—P4–02–05. http://dx.doi.org/10.1158/1538-7445.sabcs21-p4-02-05.

Повний текст джерела
Анотація:
Abstract Introduction: While endocrine therapy is an effective, well-tolerated treatment for estrogen receptor positive breast cancer (ER+BC), a large proportion of initial responders will develop hormone therapy resistance, and relapse. A major challenge in determining the mechanisms underlying endocrine therapy resistance is our limited ability to recapitulate inter- and intra-tumour heterogeneity in vitro. In this study we developed ER+BC cells resistant to estrogen deprivation, and to palbociclib treatment, and subjected these to 2D and 3D high-throughput drug and siRNA screens, in order t
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Younes, Anas, Ian W. Flinn, Yasuhiro Oki, et al. "A First-In-Man Phase 1 Study Of CUDC-907, a First-In-Class Chemically-Designed Dual Inhibitor Of PI3K and HDAC In Patients With Refractory Or Relapsed Lymphoma and Multiple Myeloma." Blood 122, no. 21 (2013): 4363. http://dx.doi.org/10.1182/blood.v122.21.4363.4363.

Повний текст джерела
Анотація:
Abstract Background PI3K and HDAC inhibitors have demonstrated single agent clinical activity in patients (pts) with a variety of B-cell malignancies, including lymphoma and multiple myeloma (MM). Preclinical experiments indicated synergistic effects between HDAC and PI3K pathway inhibitors. CUDC-907 is a chemically-designed small molecule that combines the active hydroxamate moiety of HDAC inhibitors with a PI3K inhibitor morpholinopyrimidine pharmacophore. CUDC-907 potently inhibits class I PI3K (alpha, beta, and delta) as well as HDACs class I and II enzymes. Preclinical experiments demonst
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Li, Xinyu, Jun Ma, Yongwei Su, et al. "Combination of Venetoclax and CUDC-907 Shows Superior Antileukemic Activity Against Acute Myeloid Leukemia Ex Vivo." Blood 128, no. 22 (2016): 1571. http://dx.doi.org/10.1182/blood.v128.22.1571.1571.

Повний текст джерела
Анотація:
Abstract Overall survival rates for adults and children with acute myeloid leukemia (AML) remain unacceptably low. Resistance to chemotherapy is the major factor contributing to such dismal overall survival rates. Chemoresistance in leukemia cell line models has been associated with overexpression of the anti-apoptotic Bcl-2 family members. As such, small molecule Bcl-2 inhibitors represent a promising strategy for treating AML. Venetoclax (ABT-199) is a Bcl-2-selective inhibitor that has demonstrated promising antileukemic activity against AML. However, initial resistance to ABT-199 remains a
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Ruz-Maldonado, Inmaculada, Patricio Atanes, Guo Cai Huang, Bo Liu, and Shanta J. Persaud. "Direct Stimulatory Effects of the CB2 Ligand JTE 907 in Human and Mouse Islets." Cells 10, no. 3 (2021): 700. http://dx.doi.org/10.3390/cells10030700.

Повний текст джерела
Анотація:
Aims: The endocannabinoid system is a complex cell-signaling network through which endogenous cannabinoid ligands regulate cell function by interaction with CB1 and CB2 cannabinoid receptors, and with the novel cannabinoid receptor GPR55. CB1, CB2, and GPR55 are expressed by islet β-cells where they modulate insulin secretion. We have previously shown that administration of the putative CB2 antagonist/inverse agonist JTE 907 to human islets did not affect the insulinotropic actions of CB2 agonists and it unexpectedly stimulated insulin secretion on its own. In this study, we evaluated whether
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Nayak, Satyaprakash, Dooyoung Lee, Steven Arkin, et al. "A Quantitative Systems Pharmacology Model for the Coagulation Network Describes Biomarker Changes Observed in a Clinical Study with FXa Variant and Predicts Age-Associated Biomarker Variations." Blood 126, no. 23 (2015): 3502. http://dx.doi.org/10.1182/blood.v126.23.3502.3502.

Повний текст джерела
Анотація:
Abstract It is known that the coagulation factor levels change with age. In this work, we have applied a quantitative systems pharmacology (QSP) model of the coagulation network to predict whether age related changes in coagulation factor levels will impact dose response for PF-05320907 on various pharmacodynamic endpoints. PF-05230907 (PF-907) is a variant of FXa, in which the conformational transition from zymogen to active protease is impaired. Binding to activated factor V facilitates its transition to the active conformation, rescues procoagulant activity and is hypothesized to localize P
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "907/.2"

1

Gertow, Karl. "Fatty acid transport proteins : candidate genes for the insulin resistance syndrome /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-907-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Fiedorow, Pawel. "Etude et optimisation de structures intégrées analogiques en vue de l'amélioration du facteur de mérite des amplificateurs opérationnels." Thesis, Lyon, INSA, 2012. http://www.theses.fr/2012ISAL0061.

Повний текст джерела
Анотація:
Rail à rail entrée - sortie, classe AB, faible consommation sont autant de critères que le concepteur d'amplificateur opérationnel (AOP) intègre pour réaliser une cellule analogique performante. Pour un AOP standard, l'accent n'est pas porté sur une caractéristique particulière mais sur l’ensemble de celle-ci. Dans le but d'augmenter le nombre de fonction par circuit intégré, la tension d'alimentation des AOPs ainsi que leur consommation en courant tendent à diminuer. L'objectif des circuits réalisés est de doubler le facteur de mérite des circuits déjà présents dans le portefeuille de STMicro
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Fritsche, Louise [Verfasser]. "Identification and functional studies of two novel serine phosphorylation sites of insulin receptor substrate (IRS)-2: Ser 675 and Ser 907 / vorgelegt von Louise Fritsche." 2010. http://d-nb.info/1009929062/34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "907/.2"

1

1912-, Terkel Studs, ed. Envelopes of sound: The art of oral history. 2nd ed. Precedent Pub., 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

1912-, Terkel Studs, ed. Envelopes of sound: The art of oral history. 2nd ed. Praeger, 1990.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

1912-, Terkel Studs, ed. Envelopes of sound: The art of oral history. 2nd ed. Praeger, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Merlini, Stefano, ed. Il potere e le libertà. Il percorso di un costituzionalista. Firenze University Press, 2019. http://dx.doi.org/10.36253/978-88-6453-907-2.

Повний текст джерела
Анотація:
Il volume raccoglie le relazioni e gli scritti presentati in occasione del Convegno svoltosi a Firenze il 1° dicembre 2017, organizzato dal Centro di studi politici e costituzionali Piero Calamandrei - Paolo Barile nel centenario della nascita di Paolo Barile. Gli interventi raccolti ricostruiscono il percorso della vita e del pensiero di Paolo Barile, dagli anni giovanili della sua formazione culturale e scientifica, all’ingresso nella magistratura, l’adesione al Partito d’Azione, la Resistenza, l’incontro con Piero Calamandrei, gli studi e l’insegnamento universitario. Insegnamento mai disgi
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Schubnell, Markus. Validation in Thermal Analysis. Carl Hanser Verlag GmbH & Co. KG, 2022. http://dx.doi.org/10.1007/978-1-56990-907-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Popkin, Jeremy D. History, historians, & autobiography. University of Chicago Press, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Pavel, Georgiev, ed. Khristii︠a︡nskata kultura v srednovekovna Bŭlgarii︠a︡: Materiali ot nat︠s︡ionalna nauchna konferent︠s︡ii︠a︡, Shumen 2-4 maĭ 2007 godina po sluchaĭ 1100 godini ot smŭrtta na Sv. kni︠a︡z Boris-Mikhail (ok. 835-907). Faber, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

A, Delle James, Mrozowski Stephen A, and Paynter Robert, eds. Lines that divide: Historical archaeologies of race, class, and gender. University of Tennessee Press, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Jamichael, Henterly, ed. Good King Wenceslas. Pan Macmillan Children's Books, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

ill, Henterly Jamichael, ed. Good King Wenceslas. Dutton, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "907/.2"

1

Gröpl, Christoph, Kay Windthorst, and Christian Coelln. "Art. 115c Erweiterte Kompetenz des Bundes." In Grundgesetz. Verlag C.H.BECK oHG, 2022. http://dx.doi.org/10.17104/9783406777219-907-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Walker, Nehemiah. "907 Nehemiah Walker Annamaboe, 2 June 1686." In The Local Correspondence of the Royal African Company of England, 1681–1699, Vol. 2: The English in West Africa, 1685–1688, edited by Robin Law. British Academy, 2001. http://dx.doi.org/10.1093/oseo/instance.00104803.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Santos, Maria Carolina, Cíntia Maria Rodrigues, and Vanessa Alves Ferreira. "EDUCAÇÃO EM SAÚDE E SUAS APLICAÇÕES NA CONSTRUÇÃO DO CONHECIMENTO DE GESTANTES." In PESQUISAS E DEBATES SOBRE A SAÚDE COLETIVA: UM INTERCÂMBIO ENTRE BRASIL E PORTUGAL. Editora Omnis Scientia, 2023. http://dx.doi.org/10.47094/978-65-81609-96-2/907-914.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Andrade, Drielly Silva, Débora Conceição Santos de Oliveira, Alisson Maia de Almeida, et al. "IMPLEMENTAÇÃO DE UM PROGRAMA DE CAPACITAÇÃO PARA RASTREIO DE PERDA AUDITIVA EM IDOSOS NA ATENÇÃO BÁSICA: Um relato de experiência." In PESQUISAS E DEBATES SOBRE A SAÚDE COLETIVA: UM INTERCÂMBIO ENTRE BRASIL E PORTUGAL. Editora Omnis Scientia, 2023. http://dx.doi.org/10.47094/978-65-81609-96-2/896-907.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Henry II. "907. Faversham Abbey." In The Letters and Charters of Henry II, King of England 1154–1189, Vol. 2: Nos. 741–1341, Beneficiaries D–H, edited by Nicholas Vincent. Oxford University Press, 2020. http://dx.doi.org/10.1093/oseo/instance.00276356.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Baxter, Richard. "907 To Francis Tallents?" In Calendar of the Correspondence of Richard Baxter, Vol. 2: 1660–1696, edited by N. H. Keeble and Geoffrey F. Nuttall. Oxford University Press, 1991. http://dx.doi.org/10.1093/oseo/instance.00009908.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

"CHAPTER 2: The new macro-environment for food, agribusiness and biofuels chains." In Food and agribusiness in 2030: a roadmap. Wageningen Academic Publishers, 2020. http://dx.doi.org/10.3920/978-90-8686-907-7_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Chuang, Hui-Ping. "2. Erste Phase: Wiederbeginn (1027–1056)." In Das Steininschriftenprojekt des Wolkenheimklosters während der Liao-Dynastie (907–1125). De Gruyter, 2017. http://dx.doi.org/10.1515/9783110534849-002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Feng-shueh, Liu. "A Study of Banquet Music and Dance at the Táng Court (618–907 ce)." In Identity and Diversity. Routledge India, 2020. http://dx.doi.org/10.4324/9780367818425-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

"Table of Contents". У Qāsim Beg Ḥayātī Tabrīzī : A CHRONICLE OF THE EARLY SAFAVIDS AND THE REIGN OF SHAH ISMĀʿĪL (907–930/1501–1524). American Oriental Society, 2018. http://dx.doi.org/10.2307/j.ctv9b2vrs.2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "907/.2"

1

Amoozgar, Zohreh, Jun Ren, Nancy Wang, et al. "907 Blockade of VEGF, angiopoietin-2, and PD1 reprograms dysfunctional endothelial cells in glioblastoma to quasi-antigen-presenting cells." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0907.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Menezes de Faria Pereira, Igor, Júlia de Vasconcellos Sales Pizelli, Maria Fernanda Escocard Santiago, Mariah Barreto Vieira, Mila Queiroga Ramos, and Luiz José de Souza. "Análise do perfil clínico dos pacientes com dengue em Campos dos Goytacazes - RJ." In Semana Científica da Faculdade de Medicina de Campos. Faculdade de Medicina de Campos, 2023. http://dx.doi.org/10.29184/anaisscfmc.v22023p25.

Повний текст джерела
Анотація:
Introdução: A dengue é uma arbovirose transmitida pela fêmea do mosquito Aedes aegypti e possui quatro sorotipos distintos (DENV-1, DENV-2, DENV-3 e DENV-4). Em 2022 foram notificados 1,4 milhões de casos no Brasil, com picos registrados em períodos chuvosos. O quadro clínico cursa principalmente com febre alta, cefaleia, mialgia, dor retro-orbitária e exantema. Dentre os sinais de alarme, pode-se citar: dor abdominal intensa, hemorragias, hipotensão e hepatomegalia. A confirmação diagnóstica é laboratorial, através do isolamento do vírus ou sorologia. O tratamento consiste em reposição volêmi
Стилі APA, Harvard, Vancouver, ISO та ін.
3

"907 MEP129 – Player-level tackle training interventions in tackle-collision sports – a scoping review." In 7th IOC World Conference on Prevention of Injury and Illness in Sport, Monaco, 29 February–2 March 2024. BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine, 2024. http://dx.doi.org/10.1136/bjsports-2024-ioc.342.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Queiroz, Aline Lima, Isadora Morelli Lopes Yabagata, and Rosângela do Socorro Pereira Ribeiro. "INCIDÊNCIAS DE CASOS DE DENGUE E SEUS SOROTIPOS NOS ANOS DE 2015 A 2019 E SUA CORRELAÇÃO COM A MÉDIA PLUVIAL NO ESTADO DO TOCANTINS." In I Congresso Brasileiro de Parasitologia Humana On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/907.

Повний текст джерела
Анотація:
Introdução: A dengue é uma patologia de etiologia viral transmitido pela fêmea hematófaga Aedes aegypti, principal mosquito vetor. Sabe-se da existência do vírus RNA com 4 sorotipos (DENV - 1, 2, 3, 4) que se apresenta desde uma evolução benigna na forma clássica até uma evolução grave. No Brasil, essa patologia está diretamente relacionada ao ciclo pluvial, ocasionando criadouros do mosquito. Objetivo: Analisar a incidência dos casos de dengue nos anos 2015 a 2019. Investigar a precipitação com o aumento do número de casos. Identificar o sorotipo mais prevalente. Material e Métodos A pesquisa
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Jameel, Abood. "Using Linear Programming Technique to Measure Minimum Costs: Ready-to-Wear Factory." In ‎4th International Conference on ‎Administrative ‎& Financial Sciences. Cihan University-Erbil, 2023. http://dx.doi.org/10.24086/icafs2023/paper.907.

Повний текст джерела
Анотація:
We suggest, in this paper, linear programming model that consists of ten variables and eighteen constraints to calculate the minimum total cost and minimum cost for each product in one of the ready-to-wear factories. This factory is producing 10 different types of products (5 types of Pants, 2 types of shirts, 1type of long Jacket, 1 type of suit and 1 type of premium suit). This model usually used to solve more complicated problems in different fields by formulating or changing the form of the problem to Linear Programming model and then solve this model by using Simplex Method. We will use S
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Ковалева, Е. В., А. Р. Елфимова, А. К. Еремкина та ін. "КЛИНИЧЕСКИЕ ОСОБЕННОСТИ ТЕЧЕНИЯ ХРОНИЧЕСКОГО ГИПОПАРАТИРЕОЗА ПО ДАННЫМ ВСЕРОССИЙСКОГО РЕГИСТРА". У X (XXIX) НАЦИОНАЛЬНЫЙ КОНГРЕСС ЭНДОКРИНОЛОГОВ с международным участием «Персонализированная медицина и практическое здравоохранение». ФГБУ «НМИЦ эндокринологии» Минздрава России, 2023. http://dx.doi.org/10.14341/cong23-26.05.23-25.

Повний текст джерела
Анотація:
ЦЕЛЬ: изучить особенности клинического течения хронического гипопаратиреоза в российской по-
 пуляции.
 МАТЕРИАЛЫ И МЕТОДЫ: исследование проведено на основе данных Всероссийского регистра паци-
 ентов с хроническим послеоперационным (п/о) и нехирургическим (н/х) гипопаратиреозом, основанного
 в 2020 году под эгидой ГНЦ ФГБУ «НМИЦ эндокринологии» Минздрава России (http://gipopt.clin-reg.ru/).
 Электронная информационно-аналитическая платформа регистра позволяет в режиме онлайн вводить
 информацию по пациентам с данной патологией в различных регионах Российской Феде
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії